Boston Scientific Reports Material Agreement & Financial Obligation

Ticker: BSX · Form: 8-K · Filed: 2024-02-27T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, debt, corporate-action

Related Tickers: BSX

TL;DR

**Boston Scientific just reported a new material agreement and financial obligation, details pending.**

AI Summary

BOSTON SCIENTIFIC CORPORATION (CIK 0000885725) filed an 8-K on February 27, 2024, reporting an 'Entry into a Material Definitive Agreement' and 'Creation of a Direct Financial Obligation' as of February 22, 2024. The filing indicates significant corporate actions, but the provided text does not disclose specific financial terms, dollar amounts, or the parties involved in these agreements. The company is incorporated in Delaware and operates in Marlborough, MA.

Why It Matters

The entry into a material definitive agreement and creation of a direct financial obligation signal significant strategic or operational changes for Boston Scientific, potentially impacting its financial structure and future performance. Investors will need to monitor for further details on the nature and terms of these commitments.

Risk Assessment

Risk Level: medium — The filing indicates significant corporate actions (material agreement, financial obligation) without providing specific terms, making the potential impact on the company's financials and operations currently unknown.

Key Players & Entities

FAQ

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is BOSTON SCIENTIFIC CORPORATION.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is February 22, 2024.

What are the primary items of information reported in this 8-K filing?

The primary items reported are 'Entry into a Material Definitive Agreement' and 'Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant'.

What is the Central Index Key (CIK) for BOSTON SCIENTIFIC CORP?

The Central Index Key (CIK) for BOSTON SCIENTIFIC CORP is 0000885725.

In which state is BOSTON SCIENTIFIC CORPORATION incorporated?

BOSTON SCIENTIFIC CORPORATION is incorporated in Delaware.

From the Filing

0000885725-24-000025.txt : 20240227 0000885725-24-000025.hdr.sgml : 20240227 20240227163736 ACCESSION NUMBER: 0000885725-24-000025 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 36 CONFORMED PERIOD OF REPORT: 20240222 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 24687613 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 8-K 1 bsx-20240222.htm 8-K bsx-20240222 0000885725 false 0000885725 2024-02-22 2024-02-22 0000885725 us-gaap:CommonStockMember 2024-02-22 2024-02-22 0000885725 bsx:SeniorNotedue2027Member 2024-02-22 2024-02-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 _____________________________________________________________________ Date of Report (Date of earliest event reported): February 22, 2024 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-11083 04-2695240 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)      300 Boston Scientific Way , Marlborough , Massachusetts                  01752-1234     (Address of principal executive offices)                           (Zip Code) ( 508 ) 683-4000 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value per share BSX New York Stock Exchange 0.625% Senior Notes due 2027 BSX27 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company    ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐ ITEM 1.01    ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On February 22, 2024, Boston

View on Read The Filing